Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07048639

Dosimetric Evaluation of Breathing Impact on PTV and Adjacent Organ At Risk in Breast Cancer Radiotherapy

The study is likely an observational study, possibly retrospective or prospective, involving patients with breast cancer undergoing radiotherapy.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

25 year–40 year

Sex eligibility

All sexes

Study type

Observational

Primary location

INMOL hospital

Lahore, Punjab Province, Pakistan

About this study

Patients with breast cancer scheduled for radiotherapy will be selected based on specific inclusion and exclusion criteria.

Patients will undergo imaging studies, such as computed tomography (CT) scans, to define the target volumes and OARs.

The study aims to provide insights into the dosimetric impact of breathing motion on PTV and OARs in breast cancer radiotherapy, which can inform strategies to improve treatment planning and delivery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient of breast cancer.
  • age 25-40

Exclusion criteria

  • Patients without breast cancer

Treatment and study plan

4D-CT (Four-Dimensional Computed Tomography)

Diagnostic Test

To assess tumor and organ motion during breathing

Primary outcomes

  1. Physician's Global Assessment (PGA) Scale with scoring details

    Time frame: 12 Months

    The Physician's Global Assessment (PGA) scale is a tool used by physicians to evaluate the overall severity of a patient's disease. It's a subjective assessment, typically on a scale of 0 to 3 or 0 to 4, with higher scores indicating more severe disease activity. The PGA focuses on the overall disease activity, considering both the severity of active manifestations and relevant laboratory results, excluding organ damage and subjective findings unrelated to disease activity.

Sponsors and collaborators

Lead sponsor

Superior University

Other

Registry information

Official study title

Dosimetric Evaluation of Breathing Impact on Planning Treatment Volumne and Adjacent Organ At Risk in Breast Cancer Radiotherapy

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Jul 2, 2025
Registry last updated
Jul 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.